These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1011 related items for PubMed ID: 19937839

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Assessment of the blood-brain barrier in CNS drug discovery.
    Jeffrey P, Summerfield S.
    Neurobiol Dis; 2010 Jan; 37(1):33-7. PubMed ID: 19664709
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Challenges for blood-brain barrier (BBB) screening.
    Jeffrey P, Summerfield SG.
    Xenobiotica; 2007 Jan; 37(10-11):1135-51. PubMed ID: 17968740
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. PK/PD assessment in CNS drug discovery: Prediction of CSF concentration in rodents for P-glycoprotein substrates and application to in vivo potency estimation.
    Caruso A, Alvarez-Sánchez R, Hillebrecht A, Poirier A, Schuler F, Lavé T, Funk C, Belli S.
    Biochem Pharmacol; 2013 Jun 01; 85(11):1684-99. PubMed ID: 23454189
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Central nervous system distribution kinetics of indinavir in rats.
    Hamidi M.
    J Pharm Pharmacol; 2007 Aug 01; 59(8):1077-85. PubMed ID: 17725849
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mitigating permeability-mediated risks in drug discovery.
    Wang J, Skolnik S.
    Expert Opin Drug Metab Toxicol; 2010 Feb 01; 6(2):171-87. PubMed ID: 20064074
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
    Wan H, Ahman M, Holmén AG.
    J Med Chem; 2009 Mar 26; 52(6):1693-700. PubMed ID: 19256501
    [Abstract] [Full Text] [Related]

  • 16. In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system.
    Feng B, Mills JB, Davidson RE, Mireles RJ, Janiszewski JS, Troutman MD, de Morais SM.
    Drug Metab Dispos; 2008 Feb 26; 36(2):268-75. PubMed ID: 17962372
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Current in vitro and in silico models of blood-brain barrier penetration: a practical view.
    Vastag M, Keseru GM.
    Curr Opin Drug Discov Devel; 2009 Jan 26; 12(1):115-24. PubMed ID: 19152220
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.